PDL Biopharma
PDLI
#8350
Rank
โ‚ฌ0.24 B
Marketcap
2,16ย โ‚ฌ
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Revenue for PDL Biopharma (PDLI)

Revenue in 2020 (TTM): โ‚ฌ73.13 Million

According to PDL Biopharma 's latest financial reports the company's current revenue is โ‚ฌ70.51 Million. In 2018 the company made a revenue of โ‚ฌ0.17 Billion a decrease over the revenue in the year 2017 that were of โ‚ฌ0.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PDL Biopharma from 2001 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ73.13 M
2018โ‚ฌ0.17 B-35.24%
2017โ‚ฌ0.26 B41.34%
2016โ‚ฌ0.18 B-61.41%
2015โ‚ฌ0.48 B1.67%
2014โ‚ฌ0.47 B23.08%
2013โ‚ฌ0.38 B18.26%
2012โ‚ฌ0.32 B3.45%
2011โ‚ฌ0.31 B4.95%
2010โ‚ฌ0.30 B8.42%
2009โ‚ฌ0.27 B8.13%
2008โ‚ฌ0.25 B
2006โ‚ฌ0.36 B48.05%
2005โ‚ฌ0.24 B191.23%
2004โ‚ฌ83.99 M32.84%
2003โ‚ฌ63.23 M53.73%
2002โ‚ฌ41.13 M5.97%
2001โ‚ฌ38.81 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
โ‚ฌ63.19 B 89,519.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ32.55 B 46,068.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ28.75 M-59.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ6.03 M-91.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
โ‚ฌ48.31 M-31.49%๐Ÿ‡บ๐Ÿ‡ธ USA